amlodipine 5 MG Oral Tablet [Norvasc]

RxCUI
212549
RxNorm name
amlodipine 5 MG Oral Tablet [Norvasc]
Display name
NORVASC (Oral Pill)
Full name
amlodipine 5 MG Oral Tablet [Norvasc]
Term type
SBD
Status
Active
Strength
5 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-11-14 08:24:05

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042005
Active start
042005
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
amlodipine besylate5 MG / 1 EACHamlodipineamlodipine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
amlodipine17767

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRNorvasc 5 MG Oral Tablet1NAMES
RxNorm Nameamlodipine 5 MG Oral Tablet [Norvasc]1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID
2 linked values
2CODES
RxCUI2125491CODES
MMSL_CODEBD6061CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0069-1530-680069-1530Norvasc amlodipine besylatePFIZER LABORATORIES DIV PFIZER INCNDA019787
58151-354-3058151-354Norvasc amlodipine besylateViatris Specialty LLCNDA019787
58151-354-7758151-354Norvasc amlodipine besylateViatris Specialty LLCNDA019787
58151-354-8858151-354Norvasc amlodipine besylateViatris Specialty LLCNDA019787

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA0197870069-1530Norvasc amlodipine besylateNDAPFIZER LABORATORIES DIV PFIZER INC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 2 of 2 · 171 matching rows.

NDC11, Source, Active table
NDC11SourceActive
58016054889rxnav_historical
58016054890rxnav_historical
58016054891rxnav_historical
58016054892rxnav_historical
58016054893rxnav_historical
58016054896rxnav_historical
58016054897rxnav_historical
58016054898rxnav_historical
58016054899rxnav_historical
58056033709rxnav_historical
58295153001rxnav_historical
60491047301rxnav_historical
60491047330rxnav_historical
60491047334rxnav_historical
60491047390rxnav_historical
61392071125rxnav_historical
61392071165rxnav_historical
61392071195rxnav_historical
62584053008rxnav_historical
62584053050rxnav_historical
62584053090rxnav_historical
63539015330rxnav_historical
63539015357rxnav_historical
64579005900rxnav_historical
64579005901rxnav_historical
64725024003rxnav_historical
65084017318rxnav_historical
65243000803rxnav_historical
65243000806rxnav_historical
65243000809rxnav_historical
65427015301rxnav_historical
65427015302rxnav_historical
65427015330rxnav_historical
65427015341rxnav_historical
65427015357rxnav_historical
65427015368rxnav_historical
65427015372rxnav_historical
66267026530rxnav_historical
66336099528rxnav_historical
67228010403rxnav_historical
67228010406rxnav_historical
67296020101rxnav_historical
67544007131rxnav_historical
67544007132rxnav_historical
67801030703rxnav_historical
67801030730rxnav_historical
67801030735rxnav_historical
68115089015rxnav_historical
68115089030rxnav_historical
68115089060rxnav_historical
68115089090rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NorvascAMLODIPINE BESYLATEViatris Specialty LLC7367289c-b0b0-466a-83e2-558e2985c29f2023-02-15Warnings, Adverse reactionsExact identifier
ndc (package): 58151-354-30
ndc (package): 58151-354-77
ndc (package): 58151-354-88
ndc (product): 58151-354
ndc11 (package): 58151035430
ndc11 (package): 58151035488
ndc11 (package): 58151035477
rxcui: 212549
NorvascAMLODIPINE BESYLATEPFIZER LABORATORIES DIV PFIZER INCabd6a2ca-40c2-485c-bc53-db1c652505ed2019-01-15Warnings, Adverse reactionsExact identifier
ndc (package): 0069-1530-68
ndc (product): 0069-1530
ndc11 (package): 00069153068
rxcui: 212549

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
abd6a2ca-40c2-485c-bc53-db1c652505edNorvasc 5 MG Oral Tablet [PSN] · amlodipine 5 MG Oral Tablet [Norvasc] [SBD] · Norvasc (as amlodipine besylate) 5 MG Oral Tablet [SY] · Norvasc 5 MG Oral Tablet [SY]429These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 199220190115
7367289c-b0b0-466a-83e2-558e2985c29fNorvasc 5 MG Oral Tablet [PSN] · amlodipine 5 MG Oral Tablet [Norvasc] [SBD] · Norvasc (as amlodipine besylate) 5 MG Oral Tablet [SY] · Norvasc 5 MG Oral Tablet [SY]410These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 199220230215
b00570ff-4081-4514-b45b-eb6f753450f5Norvasc 5 MG Oral Tablet [PSN] · amlodipine 5 MG Oral Tablet [Norvasc] [SBD] · Norvasc (as amlodipine besylate) 5 MG Oral Tablet [SY] · Norvasc 5 MG Oral Tablet [SY]41These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 198720101228

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
7367289c-b0b0-466a-83e2-558e2985c29fThese highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992Viatris Specialty LLC20230215
fc285a1f-9b43-4bdf-8679-44e25654b84cThese highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992PD-Rx Pharmaceuticals, Inc.20220418
abd6a2ca-40c2-485c-bc53-db1c652505edThese highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992PFIZER LABORATORIES DIV PFIZER INC20190115
182453c3-87dd-47a4-aa53-7c54995d74fbNational Council for Prescription Drug Programs20120724
3bafdaac-fccd-4fdb-904e-5c1b7a5d3fceNational Council for Prescription Drug Programs20120724
4063d41e-0822-47a5-960c-43bdf7dfe5a4National Council for Prescription Drug Programs20120724
8801fad1-126b-49e9-9b30-ed21a3ece578National Council for Prescription Drug Programs20120724
92cdc86c-83f1-4e61-944f-70612e605f56National Council for Prescription Drug Programs20120724
a16bbc6c-972f-430d-bac6-bd31174117eaNational Council for Prescription Drug Programs20120724
dd95de65-d368-40c3-aa09-7f4dee8f9dccNational Council for Prescription Drug Programs20120724
b00570ff-4081-4514-b45b-eb6f753450f5These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1987Rebel Distributors Corp20101228

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC08CADihydropyridine derivativesATC1-4amlodipine
FDASPLD004095DihydropyridinesCHEMhas_chemical_structureamlodipine
FDASPLN0000175566Calcium Channel BlockerEPChas_epcamlodipine
FDASPLN0000175421Dihydropyridine Calcium Channel BlockerEPChas_epcamlodipine
FDASPLN0000000069Calcium Channel AntagonistsMOAhas_moaamlodipine
FDASPLN0000190114Cytochrome P450 3A InhibitorsMOAhas_moaamlodipine
MEDRTD017311AmlodipineCHEMhas_ingredientamlodipine
MEDRTD000788Angina Pectoris, VariantDISEASEmay_treatamlodipine
MEDRTD003324Coronary Artery DiseaseDISEASEmay_treatamlodipine
MEDRTD004342Drug HypersensitivityDISEASEci_withamlodipine
MEDRTD006973HypertensionDISEASEmay_treatamlodipine
MEDRTD007022HypotensionDISEASEci_withamlodipine
MEDRTN0000020065L-Calcium Channel Receptor AntagonistsMOAhas_moaamlodipine
MEDRTN0000008375Coronary Arterial VasodilationPEhas_peamlodipine
MEDRTN0000178477Decreased Blood PressurePEci_peamlodipine
MEDRTN0000178477Decreased Blood PressurePEhas_peamlodipine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH5 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESNDANDA019787
NAMESPrescribable SynonymNorvasc 5 MG Oral Tablet
NAMESTallman SynonymamLODIPine 5 MG Oral Tablet [Norvasc]
NAMESTallman SynonymNorvasc (as amLODIPine besylate) 5 MG Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon